CANCER RESEARCH INSTITUTE INC
Balance Sheet
Fiscal Year Start:
Jul 1
Assets in 2024 (Year End)
$133,734,670
Investments
72%
Receivables (Non-Related)
16%
Cash & Equivalents
11%
Other Assets
1%
Prepaid Expenses
<1%
Property, Plant, & Equipment (net)
<1%
Related-Party Receivables
0%
Inventories
0%
Liabilities in 2024 (Year End)
$66,904,035
Grants Payable
95%
Other Liabilities
3%
Payables & Accruals
2%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$16,686,936
$14,701,531
-12%
Receivables (Non-Related)
$25,349,014
$20,759,565
-18%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$288,340
$525,644
+82%
Investments
$93,121,191
$95,729,188
+3%
Property, Plant, & Equipment (net)
$113,116
$100,228
-11%
Other Assets
$2,450,267
$1,918,514
-22%
Total Assets
$138,008,864
$133,734,670
-3%
Liabilities
2023
2024
Change
Payables & Accruals
$667,567
$1,043,117
+56%
Grants Payable
$66,778,175
$63,844,049
-4%
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$2,567,268
$2,016,869
-21%
Total Liabilities
$70,013,010
$66,904,035
-4%
Net assets
2023
2024
Change
Restricted Net Assets
$23,302,031
$16,710,667
-28%
Unrestricted Net Assets
$44,693,823
$50,119,968
+12%
Net assets
2023
2024
Change
Net assets
+$67,995,854
+$66,830,635
-2%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)